HR Execs on the Move

Recruitics

www.recruitics.com

 
Recruitics is a data-centric recruitment marketing agency that makes it easy for the world’s leading brands to attract and hire great talent.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Candace Kraemer
VP of Sales Profile
Christina Lindahl
Director, Human Resources Profile
deliver Tuttle
Chief Revenue Officer Profile
Priscilla McMahon
Chief People Officer Profile
Jon Jewell
Sales Director Profile

Similar Companies

HealthEC

HealthEC is a Best In KLAS population health platform designed to elevate quality of care and patient experience by overcoming the healthcare industrys toughest data challenges.

Blue Prism

Blue Prism is the global leader in intelligent automation, transforming the way work is done. At Blue Prism, we have users in over 150 countries in more than 1,800 businesses, including Fortune 500 and public sector organizations, that are creating value with new ways of working, unlocking efficiencies, and returning millions of hours of work back into their businesses. Our intelligent digital workforce is smart, secure, scalable and accessible to all; freeing up humans to re-imagine work.

Ambassador Education Solutions

From print and digital course materials to inclusive access, OER and more, Ambassador simplifies course materials programs. Connect with us today.

PayMotion

PayMotion provides a multi-channel commerce platform designed and optimized for small and medium-sized businesses to sell online across web, mobile and social media storefronts.

Perthera

Perthera, Inc. is a service company that helps guide patients and their physicians to the best cancer treatment options available by bridging the gap between molecular testing and patient therapy. We provide a more complete view of the molecular pathways driving advanced stage cancer than any other company. By combining genomics, proteomics and clinical history, Perthera delivers a comprehensive molecular analysis of a patient`s tumor and identifies the best available FDA approved therapies and clinical trials for each individual patient.